Phenylacetylglutamine increases the susceptibility of ventricular arrhythmias in heart failure mice by exacerbated activation of the TLR4/AKT/mTOR signaling pathway-Reference-Cited by-同舟云学术

Phenylacetylglutamine increases the susceptibility of ventricular arrhythmias in heart failure mice by exacerbated activation of the TLR4/AKT/mTOR signaling pathway

Published:2023-03 Issue: Volume:116 Page:109795
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Fu Hui,Kong Bin,Zhu Jun,Huang He,Shuai Wei^ORCID

Funder

Natural Science Foundation of Hubei Province

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference46 articles.

1. Temporal trends in prevalence and prognostic implications of comorbidities among patients with acute decompensated heart failure The ARIC study community surveillance;Pandey;Circulation,2020

2. The cardiology society of india-kerala acute heart failure registry: poor adherence to guideline-directed medical therapy;Joseph;Eur. Heart J.,2022

3. Clinical course of patients with worsening heart failure with reduced ejection fraction;Butler;J. Am. College of Cardiol.,2019

4. Pathophysiology and therapeutic approaches to acute decompensated heart failure;Njoroge;Circulation Res.,2021

5. Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction;Bouter;Gastroenterol.,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nimbolide protects against diabetic cardiomyopathy by regulating endoplasmic reticulum stress and mitochondrial function via the Akt/mTOR pathway;Tissue and Cell;2024-10

2. Identification of Chagas disease biomarkers using untargeted metabolomics;Scientific Reports;2024-08-13

3. Effects of Phenylacetylglutamine on the Susceptibility of Atrial Fibrillation in Overpressure-Induced HF Mice;Molecular and Cellular Biology;2024-04-02

4. Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights;Frontiers of Medicine;2024-02

5. Prognostic value of gut microbe‐generated metabolite phenylacetylglutamine in patients with heart failure;European Journal of Heart Failure;2024-01-25